{"id":"https://openalex.org/W4286299147","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.2504","title":"Phase 1 trial of TIM-3 inhibitor cobolimab monotherapy and in combination with PD-1 inhibitors nivolumab or dostarlimab (AMBER).","display_name":"Phase 1 trial of TIM-3 inhibitor cobolimab monotherapy and in combination with PD-1 inhibitors nivolumab or dostarlimab (AMBER).","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286299147","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.2504"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.2504","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.2504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.2504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069777765","display_name":"Gerald Steven Falchook","orcid":"https://orcid.org/0000-0001-9165-2191","observed_orcids":["https://orcid.org/0000-0001-9165-2191"]},"institutions":[{"id":"https://openalex.org/I4210120438","display_name":"HealthONE","ror":"https://ror.org/032y5sx52","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210120438"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald Steven Falchook","raw_affiliation_strings":["Sarah Cannon Research Institute at HealthONE, Denver, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute at HealthONE, Denver, CO;","institution_ids":["https://openalex.org/I4210120438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083745558","display_name":"Antoni Ribas","orcid":"https://orcid.org/0000-0003-3669-8458","observed_orcids":["https://orcid.org/0000-0003-3669-8458"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antoni Ribas","raw_affiliation_strings":["University of California Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030169825","display_name":"Diwakar Davar","orcid":"https://orcid.org/0000-0002-7846-8055","observed_orcids":["https://orcid.org/0000-0002-7846-8055"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diwakar Davar","raw_affiliation_strings":["University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025872938","display_name":"Zeynep Eroglu","orcid":"https://orcid.org/0000-0002-2307-7030","observed_orcids":["https://orcid.org/0000-0002-2307-7030"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zeynep Eroglu","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030087036","display_name":"Judy Sing-Zan Wang","orcid":"https://orcid.org/0000-0003-4789-4913","observed_orcids":["https://orcid.org/0000-0003-4789-4913"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judy S. Wang","raw_affiliation_strings":["Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason J. Luke","raw_affiliation_strings":["University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003060935","display_name":"Erika Paige Hamilton","orcid":"https://orcid.org/0000-0002-1911-0336","observed_orcids":["https://orcid.org/0000-0002-1911-0336"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika P. Hamilton","raw_affiliation_strings":["Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN;","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078930990","display_name":"Brian Di Pace","orcid":"https://orcid.org/0000-0003-0568-9970","observed_orcids":["https://orcid.org/0000-0003-0568-9970"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Di Pace","raw_affiliation_strings":["GSK, Collegeville, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Collegeville, PA;","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101604046","display_name":"Tianli Wang","orcid":"https://orcid.org/0000-0003-0298-8377","observed_orcids":["https://orcid.org/0000-0003-0298-8377"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tianli Wang","raw_affiliation_strings":["GSK, Collegeville, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Collegeville, PA;","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024595838","display_name":"Srimoyee Ghosh","orcid":"https://orcid.org/0000-0002-7820-6741","observed_orcids":["https://orcid.org/0000-0002-7820-6741","https://orcid.org/0000-0002-6832-2917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Srimoyee Ghosh","raw_affiliation_strings":["GSK, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Waltham, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090627816","display_name":"Arindam Dhar","orcid":"https://orcid.org/0000-0002-7929-0877","observed_orcids":["https://orcid.org/0000-0002-7929-0877"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arindam Dhar","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA;","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011168624","display_name":"Theo Borgovan","orcid":"https://orcid.org/0009-0000-6029-4002","observed_orcids":["https://orcid.org/0009-0000-6029-4002","https://orcid.org/0000-0002-8083-9476"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theo Borgovan","raw_affiliation_strings":["GSK, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Waltham, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011603360","display_name":"Angela Waszak","orcid":"https://orcid.org/0009-0005-8620-0488","observed_orcids":["https://orcid.org/0009-0005-8620-0488"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Waszak","raw_affiliation_strings":["GSK, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Waltham, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064953304","display_name":"Patricia Mucci LoRusso","orcid":"https://orcid.org/0000-0001-7144-036X","observed_orcids":["https://orcid.org/0000-0001-7144-036X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia LoRusso","raw_affiliation_strings":["Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"2504","last_page":"2504"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8500000238418579},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dostarlimab","display_name":"dostarlimab","score":1.0},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8870000243186951},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.949999988079071},{"id":"https://openalex.org/keywords/mesothelioma","display_name":"mesothelioma","score":0.843999981880188},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6830000281333923},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7699999809265137},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.8009999990463257},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.5619999766349792},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.5920000076293945},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8487862348556519},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8069660067558289},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.7980185151100159},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7919026613235474},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6941874623298645},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6414365768432617},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6228027939796448},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5624443292617798},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5491554737091064},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4882238209247589},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.48377272486686707},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.4546530544757843},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34590643644332886},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3455008864402771},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.13364732265472412}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.2504","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.2504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.2504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281780203","https://openalex.org/W4388071789","https://openalex.org/W4411580981","https://openalex.org/W4411580900","https://openalex.org/W3123341232","https://openalex.org/W2959586017","https://openalex.org/W4200320597","https://openalex.org/W3212804507","https://openalex.org/W3102540340","https://openalex.org/W3156148127"],"abstract_inverted_index":{"2504":[0],"Background:":[1],"TIM-3":[2],"expressed":[3],"on":[4],"tumor-infiltrating":[5],"T":[6],"cells":[7],"is":[8,15],"associated":[9],"with":[10,21,33],"T-cell":[11],"suppression.":[12],"AMBER":[13],"(NCT02817633)":[14],"evaluating":[16],"cobolimab":[17,45,63,74],"(TSR-022/GSK4069889)":[18],"monotherapy":[19,48,97],"and":[20,56,72,91,98,124,127,139,144,147,182,192,199,201,205,210,222,244,256,280,282,285,315,327,339],"PD-1":[22],"inhibitors":[23],"in":[24,122,164,169,177,187,217,239,251,264,267,276,287,293,352],"advanced":[25],"solid":[26],"tumors.":[27],"Methods:":[28],"Multi-center,":[29],"open-label":[30],"study":[31],"conducted":[32],"the":[34,299,348],"following":[35],"escalation":[36],"arm":[37],"(Parts":[38],"1A\u2013C":[39],"primary":[40],"analysis":[41],"reported":[42],"here):":[43],"(1A)":[44],"(IV":[46],"Q2W)":[47],"at":[49,298],"7":[50],"doses":[51,321],"(6":[52],"weight-based":[53],"[0.03\u201310":[54],"mg/kg]":[55],"1":[57],"flat":[58],"[1200":[59],"mg]":[60],"dose);":[61],"(1B)":[62],"(1":[64],"mg/kg)":[65],"+":[66,80,334,350],"nivolumab":[67],"(3":[68],"mg/kg":[69,314,320],"IV":[70,84],"Q2W);":[71],"(1C)":[73],"(100,":[75],"300,":[76],"or":[77,110,230],"900":[78],"mg)":[79],"dostarlimab":[81,335],"(500":[82],"mg":[83],"Q3W).":[85],"Primary":[86],"endpoints":[87],"were":[88,104,133,226],"safety,":[89],"tolerability,":[90],"recommended":[92],"phase":[93,306,355],"2":[94,356],"dose":[95,234,295,301],"(RP2D,":[96],"combination).":[99],"Results:":[100],"104":[101],"patients":[102],"(pts)":[103],"included:":[105],"1A":[106,116,123,188,268],"(n=46),":[107],"1B":[108,195,277],"(n=7),":[109],"1C":[111,120,125,206],"(n=55);":[112],"4":[113],"pts":[114],"from":[115,309],"crossed":[117],"over":[118],"to":[119,233,249],"(included":[121],"safety":[126],"efficacy":[128],"analyses).":[129],"Most":[130],"common":[131],"cancers":[132],"non-small":[134],"cell":[135],"lung":[136],"cancer":[137],"(NSCLC)":[138],"melanoma":[140],"(1A),":[141,179,219,241,253,322],"NSCLC":[142],"(1B),":[143,181,221,243,255],"NSCLC,":[145],"skin,":[146],"peritoneal":[148],"mesothelioma":[149],"(1C).":[150,224,246,258],"In":[151],"1A,":[152],"30.4%":[153],"had":[154,162,167],"\u22655":[155],"lines":[156],"(L)":[157],"of":[158,347],"prior":[159],"therapy;":[160],"42.9%":[161],"3L":[163],"1B;":[165],"33.3%":[166],"2L":[168],"1C.":[170,288,331],"Treatment-related":[171],"treatment-emergent":[172],"adverse":[173],"events":[174],"(TR-TEAE)":[175],"occurred":[176,216,238,263],"67.4%":[178],"85.7%":[180],"67.3%":[183],"(1C);":[184],"most":[185],"commonly":[186],"(n\u22654)":[189],"fatigue":[190,208],"(13.0%)":[191],"nausea":[193,200],"(8.7%);":[194],"(n\u22653)":[196],"diarrhea":[197,279],"(57.1%)":[198],"vomiting":[202],"(42.9%":[203],"each);":[204],"(n\u22658)":[207],"(20.0%)":[209],"rash":[211],"(14.5%).":[212],"Grade":[213],"(Gr)\u22653":[214],"TR-TEAEs":[215,229,231,237,247],"4.3%":[218],"28.6%":[220,254],"14.5%":[223],"There":[225],"no":[227],"Gr5":[228],"leading":[232],"delay.":[235],"Serious":[236],"2.2%":[240,252],"0%":[242,286],"12.7%":[245],"led":[248],"discontinuation":[250],"9.0%":[257],"Dose":[259],"limiting":[260],"toxicities":[261],"(DLTs)":[262],"3.0%":[265],"(1/33)":[266],"(Gr3":[269,278],"lipase":[270],"increased":[271,292],"[10":[272],"mg/kg]);":[273],"40.0%":[274],"(2/5)":[275],"ALT":[281],"AST":[283],"elevation);":[284],"Cobolimab":[289,333],"serum":[290],"exposure":[291],"a":[294,353],"proportional":[296],"manner":[297],"therapeutic":[300],"range.":[302],"Preliminary":[303],"mean":[304],"terminal":[305],"t1/2":[307],"ranged":[308],"2.5\u20135.8":[310],"days":[311,317,324,329],"for":[312,318,325,330],"0.03\u20130.3":[313],"6.9\u201310.2":[316],"1\u201310":[319],"6.9":[323],"1B,":[326],"9.5\u201312.3":[328],"Conclusions:":[332],"was":[336],"well":[337],"tolerated":[338],"showed":[340],"preliminary":[341],"anti-tumor":[342],"activity,":[343],"warranting":[344],"further":[345],"investigation":[346],"RP2D":[349],"docetaxel":[351],"randomized,":[354],"study.":[357],"Funding:":[358],"GSK":[359],"(213348).":[360],"Clinical":[361],"trial":[362],"information:":[363],"NCT02817633.":[364],"[Table:":[365],"see":[366],"text]":[367]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":24},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-07-21T00:00:00"}